ZPD A/S: Financial statements 2019
CVR: 32834825
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
ZPD A/S (CVR 32834825) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 36,750,000 and a net result of DKK 7,705,000 compared with DKK 11,439,000 the year before. That is a decrease of 11.5% compared with the year before. Equity in the 2019 report amounted to DKK 165,249,000. The solvency ratio was 94.4%. The company had 33 employees in the financial year.
- Gross Profit
- DKK 36,750,000
- Profit/Loss
- DKK 7,705,000
- Equity
- DKK 165,249,000
- Total Assets
- DKK 175,018,000
- Employees
- 33
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 36.8 mio. | 7.7 mio. | 165.2 mio. | 33 |
| 2018 | - | 41.5 mio. | 11.4 mio. | 157.5 mio. | 32 |
| 2017 | - | 40.8 mio. | 11.2 mio. | 146.1 mio. | 28 |
| 2016 | - | 39.8 mio. | 10.9 mio. | 134.9 mio. | 28 |
| 2015 | - | 47.8 mio. | 19.8 mio. | 124 mio. | 27 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
ZPD A/S has published its annual report for 2018. Gross profit came to DKK 41,504,000, and the net result was DKK 11,439,000.
As of February 8, 2019, Yoshihiro Hiraga has joined the board of directors of ZPD A/S.
As of February 8, 2019, Hiroki Kato has left the board of directors of ZPD A/S.
About ZPD A/S
ZPD A/S is a Danish company of the type Aktieselskab based in Esbjerg, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named BIOFAC ESBJERG A/S. The management consists of Frank Marek and Hiroyuki Shinya. The board consists of Masakazu Sakurai (chair), Frank Marek and Ken Motegi. The company is owned by Zeria Pharmaceutical Co. Ltd.. The company has 54 employees (2026). In 2025, the company reported a gross profit of DKK 52,704,000 and a net result of DKK 10,220,000 compared with DKK 12,864,000 the year before. Equity in the 2025 report amounted to DKK 217,641,000.